Chromosomal fragile sites and DNA amplification in drug-resistant cells

Biochemical Pharmacology

Volumn 56, Issue 1, 1998, Pages 7-13

  Kuo, M Tien ^a   Sen, Subrata ^a   Hittelman, Walter N ^a   Hsu, T C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancers; Chromosome breaks; DNA amplification; Drug resistance; Fragile sites

Indexed keywords

ANTINEOPLASTIC AGENT; DISTAMYCIN A; VINBLASTINE; VINCRISTINE;

ANIMAL CELL; CANCER; CHO CELL; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITE; CHROMOSOME TRANSLOCATION; DNA REPAIR; DNA STRAND BREAKAGE; DRUG RESISTANCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HAMSTER; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031751078     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00040-9     Document Type: Article

References (63)

1. Schimke RT, Gene amplification: What are we learning? Mutat Res 276: 145-149, 1992.
2. Stark GR, Regulation and mechanisms of mammalian gene amplification. Adv Cancer Res 61: 87-113, 1993.
3. Wahl GM, The importance of circular DNA in mammalian gene amplification. Cancer Res 49: 1333-1340, 1989.
4. Windle BE and Wahl GM, Molecular dissection of mammalian gene amplification: New mechanistic insights revealed by analyses of very early events. Mutat Res 276: 199-224, 1992.
5. Hamlin JL, Leu TH, Vaughn JP, Ma C and Dijkwel PA, Amplification of DNA sequences in mammalian cells. Prog Nucleic Acid Res Mol Biol 41: 203-239, 1991.
6. Biedler JL, Evidence for transient or prolonged extrachromosomal existence of amplified DNA sequences in antifolate-resistant, vincristine-resistant, and human neuroblastoma cells. In: Gene Amplification (Ed. Schimke RT), pp. 39-45. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1982.
7. Sen S, Teeter LD and Kuo MT, Specific gene amplification associated with consistent chromosomal abnormality in independently established multidrug resistant Chinese hamster ovary cells. Chromosoma 95: 117-125, 1987.
8. Biedler JL, Chang TD, Scotto KW, Melera PW and Splengler BA, Chromosomal organization of amplified genes in multidrug-resistant Chinese hamster cell lines. Cancer Res 48: 3179-3188, 1988.
9. Kuo MT, Vyas RC, Jiang L-X and Hittelman WN, Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol Cell Biol 14: 5202-5211, 1994.
10. Trask BJ and Hamlin JL, Early dihydrofolate reductase gene amplification events in CHO cells usually occur on the same chromosome arm as the original locus. Genes Dev 3: 1913-1925, 1989.
11. Smith KA, Gorman PA, Stark MB, Groves RP and Stark GR, Distinctive chromosomal structures are formed very early in the amplification of CAD genes in Syrian hamster cells. Cell 63: 1219-1227, 1990.
12. Toledo F, Smith KA, Buttin G and Debatisse M, The evolution of the amplified adenylate deaminase 2 domains in Chinese hamster cells suggests the sequential operation of different mechanisms of DNA amplification. Mutat Res 276: 261-273, 1992.
13. Toledo F, Le Roscouet D, Buttin G and Debatisse M, Co-amplified markers alternate in megabase long chromosomal inverted repeats and cluster independently in interphase nuclei at early steps of mammalian gene amplification. EMBO J 11: 2665-2673, 1992.
14. Coquelle A, Pipiras E, Toledo F, Buttin G and Debatisse M, Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89: 215-225, 1997.
15. Ma C, Martin S, Trask B and Hamlin JL, Sister chromatid fusion initiates amplification of the reductase gene in Chinese hamster cells. Genes Dev 7: 605-620, 1993.
16. Kaufman RJ, Sharp PA and Latt SA, Evolution of chromosomal regions containing transfected and amplified dihydrofolate reductase sequences. Mol Cell Biol 3: 699-711, 1983.
17. Pathak S, Centromere or telomere: Who is the boss? Anticancer Res 15: 2549-2550, 1995.
18. Smith KA, Stark MB, Gorman PA and Stark GR, Fusions near telomeres occur very early in the amplification of CAD genes in Syrian hamster cells. Proc Natl Acad Sci USA 89: 5427-5431, 1992.
19. Windle B, Draper BW, Yin Y, O'Gorman S and Wahl GM, A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes Dev 5: 160-174, 1991.
20. Stahl F, Wettergren Y and Levan G, Amplicon structure in multidrug-resistant murine cells: A non-rearranged region of genomic DNA corresponding to large circular DNA. Mol Cell Biol 12: 1179-1187, 1992.
21. Hahn P, Nevaldine B and Longo JA, Molecular structure and evolution of double-minute chromosomes in methotrexate-resistant cultured mouse cells. Mol Cell Biol 12: 2911-2918, 1992.
22. Van der Bliek AM, Lincke CR and Borst P, Circular DNA of 3T6R50 double minute chromosome. Nucleic Acids Res 16: 4841-4851, 1988.
23. Ruiz JC, Choi K, von Hoff DD, Roninson IB and Wahl GM, Autonomously replicating episomes contain mdr1 genes in a multidrug-resistant human cell line. Mol Cell Biol 9: 109-115, 1989.
24. Chen TL and Manuelidis L, Neuroblastoma double minutes isolated by pulsed-field gel electrophoresis without prior strand cleaving treatments. Genomics 4: 430-433, 1989.
25. Beverley SM, Coderre JA, Santi DV and Schimke RT, Unstable DNA amplifications in methotrexate-resistant Leishmania consist of extrachromosomal circles which relocalize during stabilization. Cell 38: 431-439, 1984.
26. Amler LC and Schwab M, Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA. Mol Cell Biol 9: 4903-4913, 1989.
27. Amler LC, Shibasaki Y, Savelyeva L and Schwab M, Amplification of the N-myc gene in human neuroblastomas: Tandemly repeated amplicons with homogeneously staining regions on different chromosomes with the retention of single copy gene at the resident site. Mutat Res 276: 291-297, 1992.
28. Schneider SS, Hiemstra JL, Zehnbauer BA, Taillon-Miller P, Le Paslier DL, Vogelstein B and Brodeur GM, Isolation and structural analysis of a 1.2-megabase N-myc amplicon from a human neuroblastoma. Mol Cell Biol 12: 5563-5570, 1992.
29. Schoenlein PV, Shen D-W, Barrett JT, Pastan I and Gottesman MM, Double minute chromosomes carrying the human multidrug resistance 1 and 2 genes are generated from the dimerization of submicroscopic circular DNAs in colchicine-selected KB carcinoma cells. Mol Biol Cell 3: 507-520, 1992.
30. Smith KA, Chernova OB, Groves RP, Stark MB, Martínez JL, Davidson JN, Trent JM, Patterson TE, Agarwal A, Duncan P, Agarwal ML and Stark GR, Multiple mechanisms of N-phosphonacetyl-L-aspartate resistance in human cell lines: Carbamyl-P synthetase/aspartate transcarbamylase/dihydro-orotase gene amplification is frequent only when chromosome 2 is rearranged. Proc Natl Acad Sci USA 94: 1816-1821, 1997.
31. Smith KA, Agarwal ML, Chernova MV, Chernova OB, Deguchi Y, Ishizaka Y, Patterson TE, Poupon MF and Stark GR, Regulation and mechanisms of gene amplification. Philos Trans R Soc Lond B Biol Sci 347: 49-56, 1995.
32. Yunis JJ, Soreng A and Bowe AE, Fragile sites are targets of diverse mutagens and carcinogens. Oncogene 1: 59-69, 1987.
33. Kunz BA, Genetic effect of deoxyribonucleotide pool imbalances. Environ Mutagen 4: 695-714, 1982.
34. Meuth M, The genetic consequences of nucleotide precursor pool imbalance in mammalian cells. Mutat Res 126: 107-112, 1984.
35. Poupon MF, Smith KA, Chernova OB, Gilbert C and Stark GR, Inefficient growth arrest in response to dNTP starvation stimulates gene amplification through bridge-breakage-fusion cycles. Mol Biol Cell 7: 345-354, 1996.
36. Sen S, Hittelman WN, Teeter LD and Kuo MT, Model for the formation of double minutes from prematurely condensed chromosomes of replicating micronuclei in drug-treated Chinese hamster ovary cells undergoing DNA amplification. Cancer Res 49: 6731-6737, 1989.
37. Tlsty TD, Brown PC and Schimke RT, UV radiation facilitates methotrexate resistance and amplification of the dihydrofolate reductase gene in cultured 3T6 mouse cells. Mol Cell Biol 4: 1050-1056, 1984.
38. Rice GC, Ling V and Schimke RT, Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (Adriamycin) resistance. Proc Natl Acad Sci USA 84: 9261-9264, 1987.
39. Rice GC, Hoy C and Schimke RT, Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci USA 83: 5978-5982, 1986.
40. Sutherland GF, Chromosomal fragile sites. Genet Anal Tech Appl 8: 161-166, 1991.
41. Hsu TC and Somers CE, Effect of 5-bromodeoxyuridine on mammalian chromosomes. Proc Natl Acad Sci USA 47: 396-403, 1990.
42. Nussbaum RL and Ledbetter DH, Fragile X syndrome: A unique mutation in man. Annu Rev Genet 20: 109-145, 1986.
43. Glover TW, Coyle-Morris J and Mogan R, Fragile sites: Overview, occurrence in acute nonlymphocytic leukemia and effects of caffeine on expression. Cancer Genet Cytogenet 19: 141-150, 1986.
44. Haeijer A, Lafage M, Mattei MG, Simonetti J, Smit E, de Lapeyriere O and Birnbaum D, Localization of HST/FGFK gene with regard to 11q13 chromosomal breakpoint and fragile site. Genes Chromosomes Cancer 3: 210-214, 1991.
45. Lammie G and Peters G, Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3: 413-420, 1991.
46. Sutherland GR, Fragile sites and cancer breakpoints: The pessimistic view. Cancer Genet Cytogenet 31: 5-7, 1988.
47. Richards RI and Sutherland GR, Simple repeat DNA is not replicated simply. Nat Genet 6: 114-116, 1994.
48. Yu S, Mangelsdorf M, Hewett D, Hobson L, Baker E, Eyre HJ, Lapsys N, Le Paslier D, Doggett NA, Sutherland GR and Richards RI, Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell 88: 367-374, 1997.
49. Rassool FV, McKeithan TW, Neilly ME, van Melle E, Espinosa R III and Le Beau MM, Preferential integration of marker DNA into the chromosomal fragile site at 3p14: An approach to cloning fragile sites. Proc Natl Acad Sci USA 88: 6657-6661, 1991.
50. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM and Huebner K, The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carconoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587-597, 1996.
51. Boldog F, Gemmill RM, West J, Robinson M, Robinson L, Li E, Roche J, Todd S, Waggoner B, Lundstrom R, Jacobson J, Mullokandov MR, Klinger H and Drabkin HA, Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum Mol Genet 6: 193-203, 1997.
52. Ong ST, Fong KM, Bader SA, Minna JD, Le Beau MM, McKeithan TW and Rassool FV, Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines. Genes Chromosomes Cancer 20: 16-23, 1997.
53. Kastan MB, Onykwere O, Sidransky D, Vogelstein B and Craig RW, Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
54. Wells RD, Collier DA, Havey JD, Shimiyu M and Wohlrab F. The chemistry and biology of unusual DNA structure adopted by oligopurine oligopyrimidine sequence. FASEB J 2: 2939-2949, 1988.
55. n repeats and heat shock elements have distinct roles in chromatin structure and transcriptional activation of the Drosophila hsp26 gene. Mol Cell Biol 13: 2802-2814, 1993.
56. Cheng KC and Loeb LA, Genomic instability and tumor progression: Mechanistic consideration. Adv Cancer Res 60: 121-156, 1993.
57. Chu G, Double strand break repair. J Biol Chem 272: 24097-24100, 1997.
58. Butler DK, Yasuda LE and Yao M-C, Induction of large DNA palindrome formation in yeast: Implications for gene amplification and genome stability in eukaryotes. Cell 87: 1115-1122, 1996.
59. Coyne RS and Yao M-C, Evolutionary conservation of sequences directing chromosome breakage and rDNA palindrome formation in tetrahymenine ciliates. Genetics 144: 1479-1487, 1996.
60. Stürzbecher H-W, Donzelmann B, Henning W, Knippschild U and Buchhop S, p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J 15: 1992-2002, 1996.
61. Buchhop S, Gibson MK, Wang XW, Wagner P, Stürzbecher H-W, and Harris CC, Interaction of p53 with the human Rad51 protein. Nucleic Acids Res 25: 3868-3874, 1997.
62. Yin Y, Tainsky MA, Bsichoff FZ, Strong LC and Wahl GM, Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53. Cell 70: 937-948, 1992.
63. Lingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD, Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935, 1992.